All Medicines articles
-
PHE/DH/DWP guidelineNHS statin intolerance pathway
A Guidelines summary covering the definition, classification, and management of statin intolerance
-
NICE guideline
NICE guideline on medicines associated with dependence or withdrawal symptoms
New summary covering recommendations on prescribing and managing withdrawal from a dependence-forming medicine or antidepressant
-
News
EMA assumes responsibility for preventing medicine shortages in Europe
The EMA will also coordinate the responses of EU and EEA countries to shortages of vital medical devices and in-vitro diagnostics in crisis situations
-
News
NHS England treats first patients with sickle cell anaemia using ’life-changing’ drug
Around 5000 patients are likely to benefit from the drug over the next 3 years
-
News
Do trigger tools improve the detection of adverse drug events?
More than 90% of adverse drug events go undetected by a voluntary reporting system, a recent study has found
-
News
MHRA issues warning on concurrent use of macrolide antibiotics in patients on hydroxychloroquine
The alert follows a review by the MHRA along with the Pharmacovigilance Expert Advisory Group of the Commission on Human Medicines
-
Independent professional body guideline
UKKA SGLT-2 inhibition in adults with kidney disease guideline
Covering the use of sodium–glucose co-transporter-2 inhibitors in the context of chronic kidney disease in adults
-
NHS guideline
NHS lipid management pathway
This Guidelines summary covers key recommendations from national guidance on lipid management for the primary and secondary prevention of cardiovascular disease
-
News
Two new treatments for COVID-19 approved by the EMA
The European Medicines Agency has approved Ronapreve (casirivimab/imdevimab) and Regkirona (regdanvimab) for use against COVID-19
-
News
New treatment for thyroid cancer available through Cancer Drugs Fund
NICE has published guidance recommending selpercatinib on the Cancer Drugs Fund for thyroid cancer
-
News
MHRA approves first oral antiviral for COVID-19
The MHRA has found the antiviral to be safe and effective following a rigorous review of the evidence
-
NICE guideline
NICE cannabis medicines guideline
Covering prescribing of cannabis-based medicines for people with intractable nausea and vomiting, chronic pain, spasticity, and severe treatment-resistant epilepsy
-
News
EMA reviewing possible new antiviral for COVID-19
The EMA begins its review of a new antiviral drug for treating COVID-19 in adults
-
News
New COVID-19 antivirals secured by UK Government
‘Groundbreaking’ COVID-19 antiviral treatments could be offered to vulnerable patients this winter
-
News
Government pledges to reduce overprescribing of medicines
The Government will take action to reduce medicines being prescribed unnecessarily in England following a new review
-
Independent professional body guideline
GMC remote prescribing principles guidance
Covering key principles for remote prescribing and an algorithm for deciding when to perform remote consultations
-
News
Royal Pharmaceutical Society updates prescriber competency framework
The Royal Pharmaceutical Society has updated its competency framework, which describes good prescribing practice across all health professions
-
News
First monoclonal antibody treatment for COVID-19 approved by MHRA
The first monoclonal antibody combination product for preventing and treating COVID-19 has been approved for use in the UK
-
News
Combined ibuprofen and paracetamol medicine to become available
A new medicine containing both ibuprofen and paracetamol has been approved for general sale without the need to visit a pharmacy
-
News
New fund proposed to provide early access to new treatments
Building on the work of the Cancer Drugs Fund, the Innovative Medicines Fund will support patients to get early access to clinically promising treatments
